IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation

Journal of Medical Virology

Volumn 56, Issue 3, 1998, Pages 224-229

  Negro, Francesco ^a,c   Giostra, Emiliano ^a   Rubbia Brandt, Laura ^a   Mentha, Gilles ^a   Colucci, Giuseppe ^b   Morel, Philippe ^a   Quadri, Rafael ^a   Perrin, Luc ^a   Hadengue, Antoine ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Anti HCV IgM; Chronic hepatitis C; Hepatitis C virus; Orthotopic

Indexed keywords

CORE PROTEIN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER TRANSPLANTATION; MALE; RECURRENT INFECTION; VIRUS CORE;

ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; FEMALE; GENOTYPE; GRAFT REJECTION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN M; IMMUNOSUPPRESSION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RNA, VIRAL; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0031720154     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199811)56:3<224::AID-JMV8>3.0.CO;2-9     Document Type: Article

References (35)

1. Araya V, Rakela J, Wright T (1997): Hepatitis C after orthotopic liver transplantation. Gastroenterology 112:575-582.
2. Battegay M (1996): Immunity to hepatitis C virus: A further piece of the puzzle. Hepatology 24:961-963.
3. Brunetto MR, Torrani Cerenzia M, Oliveri F, Piantino P, Randone A, Calvo P-L, et al. (1993): Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. Journal of Hepatology 19: 431-436.
4. Bukh J, Purcell RH, Miller RH (1992): Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction. Proceedings of the National Academy of Sciences U.S.A. 89:187-191.
5. Caporaso N, Morisco F, Romano M, Persico M, de Sio I, Tuccillo C (1994): IgM anti-HCV core in HCV RNA positive subjects with and without chronic liver disease. Italian Journal of Gastroenterology 26:347-348.
6. Chazouilleres O, Kim M, Combs C, Ferrell L, Bacchetti P, Roberts J, Ascher NL, Neuwald P, Wilber J, Urdea M, Quan S, Sanchez-Pescador R, Wright TL (1994): Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology 106:994-999.
7. Colloredo Mels G, Bellati G, Leandro G, Brunetto MR, Vicari O, Borzio M, et al. (1994): Fluctuations of viremia, aminotransferases and IgM antibody to hepatitis B core antigen in chronic hepatitis B patients with disease exacerbations. Liver 14:175-81.
8. Crespo J, Carte B, Lozano JL, Casafont F, Rivero M, de la Cruz F, Pons-Romero F (1997): Hepatitis C virus recurrence after liver transplantation: Relationship to anti-HCV core IgM, genotype, and level of viremia. American Journal of Gastroenterology 92: 1458-1462.
9. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994). Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513-1520.
10. Farci P, Gerin JL, Aragona M, Lindsey I, Crivelli O, Balestrieri A, et al. (1986): Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus. JAMA 255:1443-1446.
11. Féray C, Gigou M, Samuel D, Paradis V, Mishiro S, Maertens G, Reynés M, Okamoto H, Bismuth H, Bréchot C (1995): Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 108:1088-1096.
12. Ferrell LD, Wright TL, Roberts J, Ascher N, Lake J (1992): Hepatitis C viral infection in liver transplant recipients. Hepatology 16:865-876.
13. Freeman RB, Tran S, Lee YM, Rohrer RJ, Kaplan MM (1996): Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation 61: 542-546.
14. Gane EJ, Naoumov NV, Qian K-P, Mondelli MU, Maertens G, Portmann BC, Lau JYN, Williams R (1996): A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology 110:167-177.
15. Gonzalez-Peralta RP, Davis GL, Lau JYN (1994): Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. Journal of Hepatology 21:255-258.
16. Govindarajan S, Gupta S, Valinluck B, Redeker AG (1989): Correlation of IgM anti-hepatitis D virus (HDV) to HDV RNA in sera of chronic HDV. Hepatology 10:34-35.
17. Gretch DR, Bacchi CE, Corey L, dela Rosa C, Lesniewski RR, Kowdley K, et al. (1995): Persistent hepatitis C virus infection after liver transplantation: Clinical and virological features. Hepatology 22: 1-9.
18. Gupta SD, Hudson M, Burroughs AK, Morris R, Rolles K, Amlot P, Scheuer PJ, Dhillon AP (1995): Grading of cellular rejection after orthotopic liver transplantation. Hepatology 21:46-57.
19. Martin P, Munoz SJ, Di Bisceglie AM, Rubin R. Waggoner JG, Armenti VT, Moritz MJ, Jarrell BE, Maddrey WC (1991): Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology 13:719-721.
20. Martinelli ALC, Brown D, Braun HB, Michel G, Dusheiko GM (1996): Quantitative assessment of hepatitis C virus RNA and IgM antibodies to hepatitis C core in chronic hepatitis C. Journal of Hepatology 24:21-26.
21. McGuinness PH, Bishop GA, Painter DM, Chan R, McCaughan GW (1996): Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. Hepatology 23:676-687.
22. Nagayama R, Miyake K, Tsuda F, Okamoto H (1994): IgM antibody to a hepatitis C virus core peptide (CP14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. Journal of Medical Virology 42:311-317.
23. Negro F, Abate ML, Mondardini A, Baldi M, Leandro G, Lombardi S, Wolfe L, Ryff JC, Verme G, Brunetto MR, Bonino F (1995): The fluctuations of hepatitis C virus (HCV)-RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon. Journal of Viral Hepatitis 2:171-174.
24. Negro F, Giostra E, Rubbia-Brandt L, Mentha G, Troonen H, Albrecht M, Michel G, Perrin L, Morel P, Hadengue A (1996a): IgM Anti-HCV core antibodies correlate with hepatitis C recurrence in liver graft recipients. Transplantation Proceedings 28:2944-2947.
25. Negro F, Troonen H, Michel G, Giostra E, Albrecht M, Perrin L, Hadengue A (1996b): Lack of monomeric IgM anti-hepatitis C virus (HCV) core antibodies in patients with chronic HCV infection. Journal of Virological Methods 60:179-182.
26. Negro F, Giostra E, Krawczynski K, Quadri R, Rubbia-Brandt L, Mentha G, Colucci G, Perrin L, Hadengue A (1998): Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: Preliminary application to the liver transplantation model. Journal of Hepatology (in press).
27. Pageaux GP, Ducos J, Coste V, Mondain AM, Fabre JM, Domergue J, Larrey D, Serre A, Michel H (1995): HCV genotypes and quantitation of HCV RNA: Relationship with HCV recurrence after liver transplantation. Hepatology 22:134A.
28. Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC (1997): Significance of IgM anti-HCV core level in chronic hepatitis C. Journal of Hepatology 27:36-41.
29. Pawlotsky JM, Remire J, Darthuy F, Intrator L, Udin L, Dhumeaux D, Duval J (1995): Is the detection of anti-hepatitis C virus core IgM influenced by the presence of serum rheumatoid factor? Journal of Medical Virology 45:68-70.
30. Quiroga JA, van Binsbergen J, Wang CY, Pardo M, Navas S, Trines C, Herrero M, Carreno V (1995): Immunoglobulin M antibody to hepatitis C virus core antigen: Correlations with viral replication, histological activity and liver disease outcome. Hepatology 22: 1635-1640.
31. Shah G, Demetris J, Gavaler JS, Lewis JH, Todo S, Starzl TE, Van Thiel DH (1992): Incidence, prevalence, and clinical course of hepatitis C following liver transplantation. Gastroenterology 103: 323-329.
32. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, Conjeevaram HS, Sallie R, Di Bisceglie AM, the Hepatitis C Study Group (1995): Volunteers blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologie, and histologic features. Annals of Internal Medicine 123: 330-337.
33. Shindo M, Arai K, Sokawa Y, Okuno T (1995): The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 22:418-425.
34. Vargas V, Krawczynski K, Martinez N, Castells L, Allende H, Carson D, Esteban R, Guardia J (1995): HCV reinfection in liver transplant recipients assessed by HCV-Ag expression in liver cells. Hepatology 22:150A.
35. Zhou S, Terrault NA, Ferrell L, Hahn JA, Lau JYN, Simmonds P, Roberts JP, Lake JR, Ascher NL, Wright TL (1996): Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: Relationship to genotype and level of viremia. Hepatology 24:1041-1046.